Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5
Name of the chemical
Potassium or sodium hydroxide (20)
Concentration
N/A
General Information
Version
3
Revision date
2022-11-21
Product name
Reef Zlements Z-pHplus Part 1 - 1, 2.5, 5, 10l
Product name
Reef Zlements Z-pHplus Part 1 - 1, 2.5, 5, 10l
Identification on the label/Trade name
Sodium Carbonate (less than 15%)
1.2.1 Relevant identified uses
Aquarium Water Supplement
Icons in SDS
Company Information
company name
Reef Zlements Limited
e-mail address of the competent person responsible for the Safety Data Sheet
info@reef-zlements.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
Classification under CLP Classification of the substance or mixture Classification under CLP: Based on available data, the classification criteria are not met
2.2 Label elements
Label elements under CLP
Hazard statements
H314 Causes severe skin burns and eye damage
Precautionary statements
P280-P301+P330+P331-P303+P361+P353-P305+P351+P338-P310 Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call emergency services immediately. Page: 2 Keep out of reach of children. Not for human consumption P270: Do not eat, drink or smoke when using this product. P314: Get medical advice/attention if you feel unwell.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
PBT Substances
This product is not identified as a PBT/vPvB substance
2.1 Classification of the substance or mixture
Classification under CLP: Based on available data, the classification criteria are not met Most important adverse effects